• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿性关节炎患者与健康对照者的组织工程化骨骼肌的差异反应。

Differential response of tissue engineered skeletal muscle from rheumatoid arthritis patients and healthy controls.

作者信息

Oliver Catherine E, Carter Jonathan L, Hong James S, Xu Mingzhi, Kraus William E, Huffman Kim M, Truskey George A

机构信息

Department of Biomedical Engineering, Duke University, Durham, NC, USA.

Department of Medicine, Duke University School of Medicine, Durham, NC, USA.

出版信息

Commun Biol. 2025 Apr 9;8(1):583. doi: 10.1038/s42003-025-07970-8.

DOI:10.1038/s42003-025-07970-8
PMID:40200033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11978753/
Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting articular joints and skeletal muscle. To assess the role of cytokines upon muscle strength in RA, we developed an in vitro tissue-engineered human skeletal muscle model (myobundle). Myobundles were generated using primary skeletal muscle cells from the vastus lateralis muscle of RA patients and age-matched healthy controls. RA myobundles were more sensitive to 5 ng/mL IFN-γ, exhibiting reduced contractile force and altered contraction kinetics. Addition of IL-6 with or without IFN-γ led to a small but significant increase in striated fibers. Gene sets involved in the response to hypoxia, MTOR1 signaling, and the unfolded protein response were enriched in IFN-γ-treated RA myobundles, but not IFN-γ-treated controls. Tofacitinib increased contractile force, myosin heavy chain, and PIM1 protein levels in RA myobundles treated with IFN-γ. Thus, in RA muscle, low levels of IFN-γ selectively increase gene pathways that reduce contractile force.

摘要

类风湿性关节炎(RA)是一种影响关节和骨骼肌的慢性炎症性疾病。为了评估细胞因子在类风湿性关节炎中对肌肉力量的作用,我们建立了一种体外组织工程化人类骨骼肌模型(肌束)。使用来自类风湿性关节炎患者股外侧肌的原代骨骼肌细胞和年龄匹配的健康对照来生成肌束。类风湿性关节炎肌束对5 ng/mL干扰素-γ更敏感,表现出收缩力降低和收缩动力学改变。添加白细胞介素-6(无论是否添加干扰素-γ)导致横纹肌纤维有小幅但显著的增加。参与缺氧反应、MTOR1信号传导和未折叠蛋白反应的基因集在干扰素-γ处理的类风湿性关节炎肌束中富集,但在干扰素-γ处理的对照中未富集。托法替布增加了用干扰素-γ处理的类风湿性关节炎肌束中的收缩力、肌球蛋白重链和PIM1蛋白水平。因此,在类风湿性关节炎肌肉中,低水平的干扰素-γ选择性地增加了降低收缩力的基因通路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/b22ea2933568/42003_2025_7970_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/d7ef5e5a8cfa/42003_2025_7970_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/938411dd92cc/42003_2025_7970_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/d2ffcb7a18bd/42003_2025_7970_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/231c6d14aff1/42003_2025_7970_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/ae23e1195e16/42003_2025_7970_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/3e6b6c7421a2/42003_2025_7970_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/400c1214fdcf/42003_2025_7970_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/b22ea2933568/42003_2025_7970_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/d7ef5e5a8cfa/42003_2025_7970_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/938411dd92cc/42003_2025_7970_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/d2ffcb7a18bd/42003_2025_7970_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/231c6d14aff1/42003_2025_7970_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/ae23e1195e16/42003_2025_7970_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/3e6b6c7421a2/42003_2025_7970_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/400c1214fdcf/42003_2025_7970_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2da2/11978753/b22ea2933568/42003_2025_7970_Fig8_HTML.jpg

相似文献

1
Differential response of tissue engineered skeletal muscle from rheumatoid arthritis patients and healthy controls.类风湿性关节炎患者与健康对照者的组织工程化骨骼肌的差异反应。
Commun Biol. 2025 Apr 9;8(1):583. doi: 10.1038/s42003-025-07970-8.
2
Tissue engineered skeletal muscle model of rheumatoid arthritis using human primary skeletal muscle cells.利用人原代骨骼肌细胞构建类风湿关节炎组织工程化骨骼肌模型。
J Tissue Eng Regen Med. 2022 Feb;16(2):128-139. doi: 10.1002/term.3266. Epub 2021 Nov 20.
3
Genetic changes from type I interferons and JAK inhibitors: clues to drivers of juvenile dermatomyositis.Ⅰ型干扰素和 JAK 抑制剂引起的遗传变化:幼年皮肌炎驱动因素的线索。
Rheumatology (Oxford). 2024 Sep 1;63(SI2):SI240-SI248. doi: 10.1093/rheumatology/keae082.
4
Tofacitinib attenuates arthritis manifestations and reduces the pathogenic CD4 T cells in adjuvant arthritis rats.托法替布可减轻佐剂性关节炎大鼠的关节炎表现并减少致病性CD4 T细胞。
Clin Immunol. 2017 Nov;184:77-81. doi: 10.1016/j.clim.2017.04.015. Epub 2017 Apr 28.
5
Exercise mimetics and JAK inhibition attenuate IFN-γ-induced wasting in engineered human skeletal muscle.运动模拟物和 JAK 抑制可减轻 IFN-γ 诱导的工程化人骨骼肌消耗。
Sci Adv. 2021 Jan 22;7(4). doi: 10.1126/sciadv.abd9502. Print 2021 Jan.
6
Cell Density and Joint microRNA-133a and microRNA-696 Inhibition Enhance Differentiation and Contractile Function of Engineered Human Skeletal Muscle Tissues.细胞密度以及关节微小RNA - 133a和微小RNA - 696的抑制可增强工程化人骨骼肌组织的分化和收缩功能。
Tissue Eng Part A. 2016 Apr;22(7-8):573-83. doi: 10.1089/ten.TEA.2015.0359.
7
Janus kinase inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin-8, but do not inhibit priming of the respiratory burst or reactive oxygen species production.Janus激酶抑制剂可阻止类风湿关节炎中性粒细胞向白细胞介素-8迁移,但不抑制呼吸爆发的启动或活性氧的产生。
Clin Exp Immunol. 2017 Aug;189(2):250-258. doi: 10.1111/cei.12970. Epub 2017 Apr 20.
8
Effect of type I interferon on engineered pediatric skeletal muscle: a promising model for juvenile dermatomyositis.Ⅰ型干扰素对工程化儿童骨骼肌的影响:幼年皮肌炎有前景的模型。
Rheumatology (Oxford). 2024 Jan 4;63(1):209-217. doi: 10.1093/rheumatology/kead186.
9
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis.托法替尼治疗类风湿关节炎患者的淋巴细胞调节作用。
Clin Exp Immunol. 2021 Aug;205(2):142-149. doi: 10.1111/cei.13609. Epub 2021 May 28.
10
Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.通过流式细胞术分析类风湿关节炎中表达CD4 +和CD8 + T细胞的Th1和Th2细胞因子
J Rheumatol. 2000 May;27(5):1128-35.

本文引用的文献

1
Skeletal muscle myostatin gene expression and sarcopenia in overweight and obese middle-aged and older adults.超重和肥胖的中老年人骨骼肌肌生长抑制素基因表达与肌肉减少症
JCSM Clin Rep. 2021 Oct;6(4):137-142. doi: 10.1002/crt2.43. Epub 2021 Sep 23.
2
Tissue engineered skeletal muscle model of rheumatoid arthritis using human primary skeletal muscle cells.利用人原代骨骼肌细胞构建类风湿关节炎组织工程化骨骼肌模型。
J Tissue Eng Regen Med. 2022 Feb;16(2):128-139. doi: 10.1002/term.3266. Epub 2021 Nov 20.
3
Hypoxic Signaling in Skeletal Muscle Maintenance and Regeneration: A Systematic Review.
骨骼肌维持与再生中的缺氧信号传导:一项系统综述
Front Physiol. 2021 Jun 23;12:684899. doi: 10.3389/fphys.2021.684899. eCollection 2021.
4
Confounding Roles of ER Stress and the Unfolded Protein Response in Skeletal Muscle Atrophy.内质网应激和未折叠蛋白反应在骨骼肌萎缩中的复杂作用。
Int J Mol Sci. 2021 Mar 4;22(5):2567. doi: 10.3390/ijms22052567.
5
Role of Interleukin-6 in Vascular Health and Disease.白细胞介素-6在血管健康与疾病中的作用。
Front Mol Biosci. 2021 Mar 16;8:641734. doi: 10.3389/fmolb.2021.641734. eCollection 2021.
6
Rheumatoid cachexia: the underappreciated role of myoblast, macrophage and fibroblast interplay in the skeletal muscle niche.类风湿性恶病质:成肌细胞、巨噬细胞和纤维母细胞相互作用在骨骼肌龛中的被低估作用。
J Biomed Sci. 2021 Mar 3;28(1):15. doi: 10.1186/s12929-021-00714-w.
7
Exercise mimetics and JAK inhibition attenuate IFN-γ-induced wasting in engineered human skeletal muscle.运动模拟物和 JAK 抑制可减轻 IFN-γ 诱导的工程化人骨骼肌消耗。
Sci Adv. 2021 Jan 22;7(4). doi: 10.1126/sciadv.abd9502. Print 2021 Jan.
8
JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data.类风湿关节炎中的JAK抑制剂:基于新出现临床数据的循证综述
J Inflamm Res. 2020 Sep 14;13:519-531. doi: 10.2147/JIR.S219586. eCollection 2020.
9
Pharmacological Interventions for Treatment of Sarcopenia: Current Status of Drug Development for Sarcopenia.治疗肌肉减少症的药物干预:肌肉减少症药物研发的现状
Ann Geriatr Med Res. 2019 Sep;23(3):98-104. doi: 10.4235/agmr.19.0028. Epub 2019 Sep 23.
10
Methotrexate and its mechanisms of action in inflammatory arthritis.甲氨蝶呤及其在炎症性关节炎中的作用机制。
Nat Rev Rheumatol. 2020 Mar;16(3):145-154. doi: 10.1038/s41584-020-0373-9. Epub 2020 Feb 17.